User covergroup4

Member for: 2 months (since Aug 12)
Type: Registered user
First Name:
Last Name:
Location:
Website: https://www.selleckchem.com/products/hc-030031.html
About: The Cycle Two Trial regarding Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic The leukemia disease.
Company:
Skills:
Facebook Profile Link:
Twitter Profile Link:

Activity by covergroup4

Score: 10 points (ranked #91)
topics: 0
replies: 0
Comments: 0
Voted on: 0 topics, 0 replies
Gave out: 0 up votes, 0 down votes
Received: 0 up votes, 0 down votes
...